Searchable abstracts of presentations at key conferences in endocrinology

ea0041ep514 | Diabetes complications | ECE2016

Assessment of neutrophil gelatinase-associated lipocalin in diabetic patients

Sazonava Alena , Mokhort Tatiana , Shyshko Volha , Mokhort Alena , Shishko Elena

Background: Diabetic nephropathy (DN) is a major cause of morbidity and mortality in type 1 diabetes (T1D) patients and associated with increased cardiovascular risk in type 2 diabetes (T2D) patients. Early detection of DN using neutrophil gelatinase-associated lipocalin (NGAL) assessment can help to reveal predisposed patients to its progression and to prevent progression of DN. Especially important it is in patients with normoalbuminuria.Aim: To determ...

ea0070aep354 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

The pattern of nerve involvement in type 1 diabetic patients with subclinical peripheral neuropathy

Mashkova Maryia , Shishko Alena , Bylodid Irina , Semushina Alena , Korshova Natalia

The concept of a subclinical form of diabetic peripheral neuropathy (DPN) is well established. Although there has been considerable research of peripheral neuropathy in type 1 diabetes, still there is controversy regarding the pattern of nerve involvement in diabetic neuropathy. Detection of the pattern of nerve involvement can help to establish a protocol for screening of DPN in its subclinical stage.Aim: The aim of this study was to describe the patter...

ea0099ep20 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Assessment of basal and stimulated C-peptide in patients with type 1 diabetes mellitus on the administration of tolerogenic dendritic cells

Mokhort Tatsiana , Shyshko Volha , Mokhort Alena , Hancharou Andrei , Antonevich Natalia , Minich Yana , Lazovtseva Volha , Dashkevich Alena , Shishko Elena

Introduction: Preserving of C-peptide secretion in type 1 diabetes mellitus (DM1) is an important goal in treatment, as it provides the possibility of optimal compensation. We initiated a study (ClinicalTrials.gov 26.01.2022, NCT05207995) to assess the potential effect of Tolerant Dendritic Cells (tolDC) on the newly diagnosed DM1.Methods: Evaluation of stimulated C-peptide against the background of a standard breakfast (carbohydrate content of 50g) was ...